Daptomycin: a novel agent for Gram-positive infections. (Q53852746)

21 May 2018

title

Daptomycin: a novel agent for Gram-positive infections. (English)

1 reference

21 May 2018

author name string

Tally FP

1

1 reference

21 May 2018

Zeckel M

2

1 reference

21 May 2018

Wasilewski MM

3

1 reference

21 May 2018

Carini C

4

1 reference

21 May 2018

Berman CL

5

1 reference

21 May 2018

Drusano GL

6

1 reference

21 May 2018

Oleson FB Jr

7

1 reference

21 May 2018

language of work or name

English

0 references

publication date

1 August 1999

1 reference

21 May 2018

Expert Opinion on Investigational Drugs

published in

1 reference

21 May 2018

volume

8

1 reference

21 May 2018

issue

8

1 reference

21 May 2018

page(s)

1223-1238

1 reference

21 May 2018

In vitro and in vivo activity of LY 146032, a new cyclic lipopeptide antibiotic

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.8.1223

In vitro activity of LY146032 against staphylococci, streptococci, and enterococci

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.8.1223

Antimicrobial activity and spectrum of LY146032, a lipopeptide antibiotic, including susceptibility testing recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.8.1223

In vitro activity of LY146032 against gram-positive bacteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.8.1223

Lipoteichoic acid as a new target for activity of antibiotics: mode of action of daptomycin (LY146032)

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.8.1223

Identification of daptomycin-binding proteins in the membrane of Enterococcus hirae

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.8.1223

Daptomycin disrupts membrane potential in growing Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.8.1223

Pharmacodynamics of daptomycin and vancomycin on Enterococcus faecalis and Staphylococcus aureus demonstrated by studies of initial killing and postantibiotic effect and influence of Ca2+ and albumin on these drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.8.1223

Investigation of the early killing of Staphylococcus aureus by daptomycin by using an in vitro pharmacodynamic model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.8.1223

In vitro pharmacodynamic effects of concentration, pH, and growth phase on serum bactericidal activities of daptomycin and vancomycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.8.1223

Comparative in vitro activity of daptomycin (LY146032) and vancomycin against gram-positive cocci determined using a pharmacokinetic model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.8.1223

In vitro response to bactericidal activity of cell wall-active antibiotics does not support the general opinion that enterococci are naturally tolerant to these antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.8.1223

Comparison of in vitro inhibitory and bactericidal activities of daptomycin (LY 146032) and four reference antibiotics, singly and in combination, against gentamicin-susceptible and high-level-gentamicin-resistant enterococci.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.8.1223

Bactericidal activities of peptide antibiotics against multidrug-resistant Enterococcus faecium

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.8.1223

Bactericidal activity of deptomycin (LY146032) compared with those of ciprofloxacin, vancomycin, and ampicillin against enterococci as determined by kill-kinetic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.8.1223

Ex vivo study of serum bactericidal titers and killing rates of daptomycin (LY146032) combined or not combined with amikacin compared with those of vancomycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.8.1223

In vitro postantibiotic effect of daptomycin (LY146032) against Enterococcus faecalis and methicillin-susceptible and methicillin-resistant Staphylococcus aureus strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.8.1223

Daptomycin (LY146032) treatment of experimental enterococcal endocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.8.1223

Comparative efficacy of daptomycin, vancomycin, and cloxacillin for the treatment of Staphylococcus aureus endocarditis in rats and role of test conditions in this determination

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.8.1223

Daptomycin or teicoplanin in combination with gentamicin for treatment of experimental endocarditis due to a highly glycopeptide-resistant isolate of Enterococcus faecium

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.8.1223

Treatment of experimental endocarditis caused by a beta-lactamase-producing strain of Enterococcus faecalis with high-level resistance to gentamicin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.8.1223

Daptomycin compared with teicoplanin and vancomycin for therapy of experimental Staphylococcus aureus endocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.8.1223

Daptomycin (LY146032) for prevention and treatment of experimental aortic valve endocarditis in rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.8.1223

Activity of LY146032 in vitro and in experimental enterococcal pyelonephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.8.1223

LY146032, alone and in combination with gentamicin, for the treatment of enterococcal pyelonephritis in the rat model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.8.1223

Comparative evaluation of daptomycin (LY146032) and vancomycin in the treatment of experimental methicillin-resistant Staphylococcus aureus osteomyelitis in rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.8.1223

Treatment of Clostridium difficile colitis in hamsters with a lipopeptide antibiotic, LY146032.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.8.1223

Comparison of the investigational drug, LY146032, with vancomycin in experimental pneumonia due to methicillin-resistant Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.8.1223

LY146032 in a hamster model of Staphylococcus aureus pneumonia--effect on in vivo clearance and mortality and in vitro opsonophagocytic killing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.8.1223

Comparison of daptomycin, vancomycin, and ampicillin-gentamicin for treatment of experimental endocarditis caused by penicillin-resistant enterococci

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.8.1223

Effect of protein binding of daptomycin on MIC and antibacterial activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.8.1223

Single-dose pharmacokinetics and antibacterial activity of daptomycin, a new lipopeptide antibiotic, in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.8.1223

Daptomycin may attenuate experimental tobramycin nephrotoxicity by electrostatic complexation to tobramycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.8.1223

Attenuation by daptomycin of gentamicin-induced experimental nephrotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.8.1223

Effects of daptomycin and vancomycin on tobramycin nephrotoxicity in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.8.1223

Influence of daptomycin on staphylococcal abscesses and experimental tobramycin nephrotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.8.1223

10.1517/13543784.8.8.1223

21 January 2018

Identifiers

DOI

1 reference

21 May 2018

PubMed ID

15992147

1 reference

21 May 2018